Gut bacteria strains could be the key to predicting cancer treatment success

FHS
March 7, 2024
2:46 am

Researchers discovered that gut microbiota strains can predict the effectiveness and adverse effects of immune checkpoint blockade (ICB) therapy in rare cancer patients.

Why Biohaven will test the FDA’s regulatory limits

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I love a

September 26, 2024

Key pressures for SMEs and business outlook in clinical research

There are many challenges small and medium sized businesses must overcome in clinical research. Credit: SFIO CRACHO via Shutterstock. The pharma sector is at a

January 14, 2025

Patent Filed by Sosei Group Corp for Novel Compounds Treating Apelin Receptor Disorders

Share this article According to GlobalData’s company profile on Sosei Group, was a key innovation area identified from patents. Sosei Group‘s grant share as of

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.